Skip to content

Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients

The Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients With Central Obesity: a Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03552237
Enrollment
40
Registered
2018-06-11
Start date
2018-06-20
Completion date
2018-12-30
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Obesity, Schizophrenia

Brief summary

Background There has been much interest in the relationship between the types of gut microbiota and the development of obesity in recent years. It has been reported that the proportions of Firmicutes and Bacteroidetes differ between obese and normal weight human subjects. Human intestinal microbiota compositions have been found to be associated with long-term dietary habits and lifestyle. However, an increasing number of researches show that intestinal microbiota composition may be affected after short-term diet intervention. Importantly, obesity and metabolic problems play important roles in morbidity and mortality of schizophrenia patients. Human intestinal microbiota compositions related with obesity may impact the heath of this population. Therefore, we searched current advances about the connection of obesity, intestinal microbiota compositions, and diet in schizophrenia to conduct a clinical research focus on the effect of high fiber diet on the intestinal microbiota of schizophrenia patients with central obesity. Method We will investigate in a 4-week intervention whether consumption of dietary fiber supplement(Inulin) affect the microbiota composition in schizophrenia inpatients with central obesity. Fecal samples from participants before and after the intervention will be processed for the microbiota analysis.

Interventions

DIETARY_SUPPLEMENTdietary fiber

We will investigate in a 4 week intervention whether consumption of dietary fiber supplement affect the microbiota composition in schizophrenia patients with central obesity.

Sponsors

TsaoTun Psychiatric Center, Department of Health, Taiwan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Schizophrenia inpatients 2. Overweight and with central obesity 3. agree to sign informed consent

Exclusion criteria

1. Diagnosis of IBS 2. Systemic antibiotic use during the past 4 weeks 3. Excessive water intake

Design outcomes

Primary

MeasureTime frameDescription
Changes from baseline in microbiota composition at week 44 weeksFecal samples from participants before and after the intervention will be processed for microbiota analysis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026